Authors


Stephen Noffsinger, MD

Latest:

Evaluating Capacity to Make a WillPsychological Autopsy and Assessment of Testamentary Capacity

It is an ancient practice to state instructions for distributing one’s property after death. In Genesis 48, Jacob verbally bequeaths his property to Joseph, Joseph’s siblings, and Joseph’s 2 sons. Wills existed in ancient Greece and Rome, with restrictions.


Stephen P. Tyrer, MD

Latest:

10 Factors Leading to Pain Complaints in the Absence of a Medical Diagnosis

With most chronic pain conditions, the exact pathology is uncertain. In such cases, psychiatrists may be called to assess for illness beyond medical diagnosis.


Stephen R. Shuchter, MD

Latest:

The Former Secret Life of an Elvis Impersonator

Stephen R. Shuchter, M.D., professor of clinical psychiatry and associate director of residency training at University of California, San Diego, spends his "down" time performing as Elvis and other rock 'n' roll legends. In these efforts, he expresses his creativity and brings delight to those he entertains. Lessons from each "career" have helped his success in the other.


Stephen Salloway, MD

Latest:

Dopamine Receptors in the Human Brain

Dopamine plays an important role in controlling movement, emotion and cognition. Dopaminergic dysfunction has been implicated in the pathophysiology of schizophrenia, mood disorders, attention-deficit disorder, Tourette's syndrome, substance dependency, tardive dyskinesia, Parkinson's disease and other disorders.


Stephen Soltys, MD

Latest:

Nonverbal Learning Disabilities and Sensory Processing Disorders

In our presentation at the 2006 annual meeting of the American Academy of Child and Adolescent Psychiatry, we suggested that child psychiatrists who come across a child with the profile of the following hypothetical case should consider whether the child may have deficits that are not currently covered by DSM-IV nosology: either a nonverbal learning disability (NVLD) or a sensory processing disorder (SPD).


Stephen Stansfeld, MBBS, MRCP, MRCPsych, PhD

Latest:

Exploring the Link Between Environmental Noise and Psychiatric Disorder

Noise, or unwanted sound, is a pollutant and an environmental stressor. The frequency of noise events seems to have increased in recent years while the amount of the day without noise has lessened.


Stephen V. Faraone, MD, PhD

Latest:

Novel Drug Delivery Systems in ADHD and Take-Home Messages

Drs Stephen Faraone, Theresa Cerulli, Craig Chepke, and Andrew J. Cutler discuss novel drug delivery systems and provide take-home messages when treating an adult with ADHD.


Stephen V. Sobel, MD

Latest:

Panic Disorder: Keys to Evidence-Based Effective Treatment

Keys to the management of panic disorder include appropriate use of psychotropic medication and psychotherapy predicated on an understanding of the disorder's biopsychosocial underpinnings. Here, Stephen V. Sobel, MD, focuses on treatment options.


Stevan M. Weine, MD

Latest:

The Limits of Advocacy

Migrant children were being endangered, with potentially devastating effects on their mental health and development, and we requested policy changes.


Stevan Weine, MD

Latest:

A Psychiatrist Investigates Poet Allen Ginsberg’s Journeys into Madness

The story of the legendary Beat poet’s involvement with madness and mental illness has never really been told—until now.


Steve Balt, MD, MS

Latest:

Assessing and Enhancing the Effectiveness of Antidepressants

With over 2 dozen FDA-approved antidepressants on the market, it is reasonable to ask: which antidepressants are most effective?


Steve H. Koh, MD, MPH

Latest:

What’s New in Depression?

The Chair of the Scientific Program Committee of APA 2016 offers an overview of the latest on depression.


Steve Koh, MD, MPH, MBA

Latest:

Introduction: The Scope of Psychiatry

Here's where psychiatry extends beyond a medical setting into collaborative, innovative, and integrated models of care..


Steve Schlozman, MD

Latest:

Child & Adolescent Psychiatry: An Overview of the Complex Challenges

We need to have a framework to make certain that our interventions are balanced, safe, and a function of the existing evidence.


Steven A. King, MD, MS

Latest:

Fibromyalgia: What It Is and How to Treat It

This CME covers the ins and outs of fibromyalgia, and everything a mental health professional needs to know when dealing with it.


Steven C. Dilsaver, MD

Latest:

Mixed States in Their Manifold Forms: Part 3

In Part 3 of this 3-part series, Dr Dilsaver discusses dichotomization versus a continuum model and concerns that bipolar disorders are over-diagnosed.


Steven D. Targum, MD

Latest:

Which Came First: Fatigue or Depression?

5 key questions to ask as part of a comprehensive differential assessment of fatigue and depression.


Steven Dilsaver, MD

Latest:

Recurrent Brief Mixed Depression

This case study of a 21-year-old woman-referred by a relative because of long-standing severe interpersonal, academic, and occupational impairment-illustrates the importance of screening patients with brief episodes of depression for mixed features.


Steven Dubovsky, MD

Latest:

Introduction: The Conventional Wisdom About Mood Disorders

What is the future of psychiatric assessment and treatment of mood disorders? The articles in this Special Report explore some important aspects and issues.


Steven H. Berger, MD

Latest:

Ethics and Dual Agency in Forensic Psychiatry

Dual agency often presents a confusing situation for the clinician who must simultaneously serve two separate roles in a legal case, such as a treatment role and a forensic role (Berger, 1997). The two roles have different purposes, procedures, relationships with the patient or evaluee, and different ethical principles.


Steven H. Hyler, MD

Latest:

Stigma Continues in Hollywood

Stereotypical portrayals of people with mental illness are as old as Hollywood itself. What are some of the clinical implications of the continued stigmatization of the mentally ill in television and film?


Steven J. Kingsbury, MD, PhD

Latest:

Psychiatric Polypharmacy: The Good, the Bad, and the Ugly

A great deal of data exists about the dangers of polypharmacy. Persons with psychiatric disorders experience increased risk for adverse drug interactions because of the great frequency with which multiple medications are used.


Steven J. Siegel, MD, PhD

Latest:

Predicting Outcome in Schizophrenia

Can sociodemographic and clinical variables predict outcome in cases of schizophrenia? Results from studies related to prognostic variables for schizophrenia have yielded interesting yet inconsistent results.


Steven L. Bernstein, MD

Latest:

Undertreatment of Tobacco Use Relative to Other Chronic Conditions

One might expect that treating nicotine use would be a leading priority for physicians. The reality is that this is not the case. More in this expert commentary, with practical tips for clinicians.


Steven P. Hamilton, MD, PhD

Latest:

The μ-Opioid System and Antidepressant Response

This article discusses the role of µ-opioid receptors (MORs) in antidepressant treatment and major depressive disorder (MDD). Specifically, it focuses on how the endogenous opioid system affects response to pharmaceuticals.


Steven P. Roose, MD

Latest:

Diagnosis and Treatment of Depressive and Memory Problems in Older Adults

What treatments are effective for mild chronic depression in older patients? Are there novel antidepressant medications with fewer adverse effects than current treatments? In this podcast, experts report on the latest updates in the evaluation and treatment of depression in older adults.


Steven Pflanz, MD

Latest:

The Art of the Unconscious

Theater, film, literature and poetry are forms of expression that allow artists and their audiences to explore the compelling issues of their lives. By understanding which pieces "speak" to patients and physicians, the dialogue and therapy may be enhanced.


Steven Phillips, MD

Latest:

Mini Quiz: Cognitive Enhancers

Which pharmacotherapeutic approach is most effective for cognitive enhancement? Test your knowledge with this quiz.


Steven R. Daviss, MD

Latest:

Update on Electronic Health Records and Health Care Technology

How to manage EHRs is at the top of the list of physician concerns, according to past AMA President Jeremy Lazarus, MD. The first psychiatrist to lead the AMA in over 70 years, Dr Lazarus addressed the Assembly at the American Psychiatric Association Annual Meeting in New York in May.


Steven S. Sharfstein, MD

Latest:

Ink Stained for Life

What was life like in the 1950s Bronx for a budding preeminent psychiatrist?

© 2024 MJH Life Sciences

All rights reserved.